AEON Biopharma, Inc. (AEON) Stock Ticker
AEON right now
Market factors today
Unlock the full AEON picture
About AEON Biopharma, Inc.
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
AEON stock facts
| Ticker symbol | AEON |
| Exchange | New York Stock Exchange Arca |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $11.6M |
| CEO | Robert Bancroft |
| Employees | 8 |
| Headquarters | Irvine, CA, US |
| IPO date | 2023-07-24 |
| Website | www.aeonbiopharma.com |
What you can see for AEON on Tickr
Live AEON price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the AEON report.
Rankings
FAQ
What is the ticker symbol for AEON Biopharma, Inc.?
The ticker symbol for AEON Biopharma, Inc. is AEON, listed on the New York Stock Exchange Arca.
What is AEON?
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity,…